Jupiter, FL, United States of America

Derek R Duckett

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 4.4

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2013-2023

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Derek R Duckett

Introduction

Derek R Duckett is a notable inventor based in Jupiter, Florida, with a significant contribution to the field of cancer research. He holds a total of four patents, showcasing his innovative approach to developing therapeutic methods for various cancers.

Latest Patents

Among his latest patents, Duckett has developed small molecule inhibitors of CDK12/CDK13. This invention provides compounds and methods for inhibiting cyclin-dependent kinases, which can be highly selective inhibitors relative to other kinases. These compounds are particularly useful in treating cancers such as breast cancer, brain cancer, and ovarian cancer. Another significant patent focuses on therapeutic targeting of casein kinase 1δ in breast cancer. This invention outlines a method for inhibiting CK1δ, demonstrating its potential in treating various cancer types, including triple-negative breast cancer and HER+ breast cancer.

Career Highlights

Duckett has worked with prestigious institutions such as The Scripps Research Institute and the University of Florida Research Foundation. His work has contributed to advancements in cancer treatment methodologies, emphasizing the importance of targeted therapies.

Collaborations

Duckett has collaborated with notable colleagues, including Theodore M Kamenecka and Rong Jiang, further enhancing the impact of his research in the scientific community.

Conclusion

Derek R Duckett's innovative contributions to cancer research through his patents and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic strategies in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…